University of Pennsylvania
Ravi Radhakrishnan is a Professor of Bioengineering, Biochemistry & Biophysics, and Chemical and Biomolecular Engineering at the University of Pennsylvania. His expertise is in chemical physics, statistical mechanics, and computational biology his laboratory is currently funded primarily by grants from US National Science Foundation, National Institutes of Health, and European Commission and focuses its research on the biophysics of single molecules and cell membranes and signaling mechanisms in cancer. Through his work, he has pioneered novel discovery platforms in insilico oncology and insilico pharmacology. Radhakrishnan and has authored over 100 articles in leading peer reviewed Journals and serves as a referee for over 50 leading journals, publishers, and federal funding agencies. He also serves as an editorial board member and associate editor for 5 journals, and also regularly serves as a Panelist and Study Section member for National Science Foundation, National Institutes of Health, and several Federal Science Foundations in the EU. Radhakrishnan is a Fellow of the American Institute of Medical and Biological Engineering.
Ravi Radhakrishnan's research interests lie at the interface of chemical physics and molecular biology. His lab's goal is to provide atomic and molecular level characterization of complex biomolecular systems and formulate quantitatively accurate microscopic models for predicting the interactions of various therapeutic agents with innate biochemical signaling mechanisms. To do so, they employ several computational algorithms ranging from techniques to treat electronic structure, molecular dynamics, Monte Carlo simulations, stochastic kinetic equations, and complex systems analyses in conjunction with the theoretical formalisms of statistical and quantum mechanics, and high performance computing in massively parallel architectures.